4.7 Article

Dual inhibitors of SARS-CoV-2 proteases: pharmacophore and molecular dynamics based drug repositioning and phytochemical leads

Journal

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
Volume 39, Issue 16, Pages 6324-6337

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/07391102.2020.1796802

Keywords

Pharmacophore; SARS-CoV-2 inhibitors; 3CL-protease; PL-protease; molecular dynamics; protease inhibitors; anti-HIV drugs; natural products

Ask authors/readers for more resources

The study presents a pharmacophore and molecular dynamics-based approach for drug repositioning and lead identification against SARS-CoV-2 dual targets. Six FDA-approved drugs and twelve natural products were identified through pharmacophore-based virtual screening. Molecular dynamics analysis revealed the importance of flexibility of the 3CLp connecting loop and the correlation between van der Waals size and binding affinity with 3CLp, as well as the negative correlation between total polar surface area and binding affinity with PLp.
SARS-related coronaviruses poses continual threat to humanity by rapidly mutating and emerging as severe pandemic outbreaks, including the current nCoV-19 pandemic. Hence a rapid drug repositioning and lead identification strategy are required to mitigate these outbreaks. We report a pharmacophore and molecular dynamics-based approach for drug repositioning and lead identification against dual targets (3CLp and PLp) of SARS-CoV-2. The pharmacophore model of 3CLp inhibitors was apolar with two aromatic and two H-bond acceptors, whereas that of PLp was relatively polar, bearing one aromatic and three H-bond acceptors. Pharmacophore-based virtual screening yielded six existing FDA-approved drugs and twelve natural products with both the pharmacophoric features. Among them are nelfinavir, tipranavir and licochalcone-D, which has shown better binding characteristics with both the proteases compared to lopinavir. The molecular dynamics revealed that the connecting loop (residues 176-199) of 3CLp is highly flexible, and hence, inhibitors should avoid high-affinity interactions with it. Lopinavir, due to its high affinity with the loop region, exhibited unstable binding. Further, the van der Waals size of the 3CLp inhibitors positively correlated with their binding affinity with 3CLp. However, the van der Waals size of a ligand should not cross a threshold of 572 angstrom(3), beyond which the ligands are likely to make high-affinity interaction with the loop and suffer unstable binding as observed in the case of lopinavir. Similarly, the total polar surface area of the ligands were found to be negatively correlated with their binding affinity with PLp.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available